节点文献
促进我国创新药研发关键技术要素的探讨
Key factors in promoting the research and development of investigational new drugs in China
【摘要】 文中通过对近年来国内化学药品研发申报的现状进行分析,结果显示我国目前是以仿制药申报为主,并逐步转向仿创结合的模式。结合在创新药研发中制药企业存在的不足,文中提出将建立创新药整体研发思路、构建适应创新研发学科需要的团队以及提高沟通交流能力作为提高我国创新药研发的关键要素。
【Abstract】 Through analysis in chemical drug submission in recent years,the current situation is confirmed.The results show that primary submissions are generic drugs,and the submission involving investigational new drug (IND) is increasing.Based on the shortcoming in IND research and development of Chinese industries,some key factors need to improve,including establishing the systematical research and development strategy,organizing the whole team,improving the communication,and so on.
【关键词】 创新药;
申报;
关键要素;
研发;
【Key words】 investigational new drug; submission; key factor; research and development;
【Key words】 investigational new drug; submission; key factor; research and development;
- 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2010年07期
- 【分类号】F426.72
- 【被引频次】8
- 【下载频次】662